Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, techmover, bz777, gentle09, whento, HighYieldStocks
Search This Board: 
Last Post: 12/10/2017 10:42:29 PM - Followers: 449 - Board type: Free - Posts Today: 52



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#61919  Sticky Note Good Overview for all new investors: bz777 12/05/17 08:03:45 PM
#61908  Sticky Note For new investors: Please DD Silicon Valley biotech, gentle09 12/05/17 06:21:44 PM
#61884  Sticky Note OTCMARKETS will no longer provide quotes for aryc. lucky,mydog 12/05/17 04:08:30 PM
#61579  Sticky Note ARYC Potential revenue streams partial list: whento 12/02/17 04:18:23 PM
#59181  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 10/26/17 12:28:09 PM
#62334   Taub is not a "debt holder" MikeCr 12/10/17 10:42:29 PM
#62333   Sorry buddy!! not getting my ARYC shares! UndervaluedStocks 12/10/17 09:26:12 PM
#62332   Don’t you love how somebody shows up a UndervaluedStocks 12/10/17 09:23:37 PM
#62330   No it gives a chance to reorganize, which Full Contact Yoga 12/10/17 08:36:01 PM
#62329   Now the tweets somehow seem uncrediable cos of Starlight84 12/10/17 08:00:46 PM
#62327   Looks like we have a solid base..Thank you UndervaluedStocks 12/10/17 07:48:16 PM
#62326   $ARYC 3 Months Chart http://www.stockscores.c $Pistol Pete$ 12/10/17 07:46:19 PM
#62325   LOL Try again. None of the updates since MikeCr 12/10/17 07:45:37 PM
#62324 ( Starlight84 12/10/17 06:52:09 PM
#62323   LOL, it’s been updated since last February. Try UndervaluedStocks 12/10/17 06:42:59 PM
#62322 ( Starlight84 12/10/17 06:37:48 PM
#62321   #alternative-facts are not facts MikeCr 12/10/17 06:35:13 PM
#62320   I agree justice will catch up to them Penny Traders Club 12/10/17 06:32:26 PM
#62319   The current PPS of this company does not UndervaluedStocks 12/10/17 06:12:32 PM
#62318   The only jury will be for prosecution of UndervaluedStocks 12/10/17 05:29:19 PM
#62317   There’s no “juries” #FAKENEWS !! UndervaluedStocks 12/10/17 05:26:51 PM
#62315   The juries in both cases will decide who's MikeCr 12/10/17 05:06:02 PM
#62312   The lawsuits are frivolous... the Taub case is Toofast 12/10/17 03:05:43 PM
#62311   #MAGA Make Arrayit Great Again UndervaluedStocks 12/10/17 03:01:35 PM
#62310   I strongly believe very soon we will settle Penny Traders Club 12/10/17 02:56:58 PM
#62308   Wow, talk about bullpoop, that's not even a Alyssa 12/10/17 02:37:52 PM
#62307   That's bulls hit... It's always in the hands The_Free_Nebula 12/10/17 02:29:57 PM
#62306   It's in the hands of RRBB, plain and Alyssa 12/10/17 02:28:27 PM
#62304   Alphabet Inc.’s medical arm Verily Life Sciences LLC TravO 12/10/17 01:24:46 PM
#62303   Arrayit reports $79,000 microarray technology inquiry from a TravO 12/10/17 01:06:33 PM
#62302   Thanks for the post TravO. Fins will tell whento 12/10/17 01:04:16 PM
#62301   wasn't the delay on the 8k beginning of jrsh 12/10/17 12:58:41 PM
#62300   Someone questioned this tweet. Asked , "why is TravO 12/10/17 12:54:57 PM
#62299   So that may be the question that you UndervaluedStocks 12/10/17 12:54:56 PM
#62298   It all depends on what they want to UndervaluedStocks 12/10/17 12:53:38 PM
#62297   well, who knows! jrsh 12/10/17 12:51:25 PM
#62296   It's shameful The_Free_Nebula 12/10/17 12:47:22 PM
#62295   This is a highly undervalued Silicon Valley biotech Penny Traders Club 12/10/17 12:46:24 PM
#62294   How many OTC companies have as many possible Penny Traders Club 12/10/17 12:45:26 PM
#62293   ARYC is NOT a P&D company. This is Penny Traders Club 12/10/17 12:40:20 PM
#62292   The gains over the last year have been UndervaluedStocks 12/10/17 12:36:10 PM
#62291   amazing isn't it? jrsh 12/10/17 12:34:47 PM
#62290   Once again I can’t wait to see what Penny Traders Club 12/10/17 12:34:37 PM
#62289   … And I’m looking forward to sharing it UndervaluedStocks 12/10/17 12:33:09 PM
#62288   Yet we are both still here :) We UndervaluedStocks 12/10/17 12:32:48 PM
#62287   Management lied to investors back then just like MikeCr 12/10/17 12:30:46 PM
#62286   Daily ARYC updates: UndervaluedStocks 12/10/17 10:51:46 AM
#62285   How was it back in 2010? UndervaluedStocks 12/10/17 10:43:09 AM
#62284   Good luck getting an answer from them even MikeCr 12/10/17 10:39:40 AM
#62283   Arrayit reports $19,000 microarray technology platform sale to UndervaluedStocks 12/10/17 09:04:12 AM
#62282   Clearly uptrend from looking at 1 year chart..things Starlight84 12/09/17 08:55:03 PM
#62281   Based on this twitter: Arrayit senior accountant at Ken1998 12/09/17 07:31:03 PM
#62280   its RRBB or bust The_Free_Nebula 12/09/17 05:35:14 PM
#62279   ridiculous.... The_Free_Nebula 12/09/17 05:18:17 PM
#62278   The company needs to file or tell why The_Free_Nebula 12/09/17 05:09:02 PM